scholarly journals Antiestrogen Therapy

2020 ◽  
Author(s):  
Keyword(s):  
Antiestrogen Therapy

Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw

2014 ◽  
Vol 42 (8) ◽  
pp. 1932-1936 ◽  
Author(s):  
Mihaly Vaszilko ◽  
Evelin Kovacs ◽  
Laszlo Restar ◽  
Bernadett Balla ◽  
Krisztina Cseplo ◽  
...  
Keyword(s):  
Osteonecrosis Of The Jaw ◽  
Potential Significance ◽  
Antiestrogen Therapy

Positron emission tomographic assessment of ?metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy

1999 ◽  
Vol 26 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Farrokh Dehdashti ◽  
Fidelma L. Flanagan ◽  
Joanne E. Mortimer ◽  
John A. Katzenellenbogen ◽  
Michael J. Welch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Positron Emission Tomographic ◽  
Positron Emission ◽  
Antiestrogen Therapy

Suppression of Unspecific Enhancement on Breast Magnetic Resonance Imaging (Mri) by Antiestrogen Medication

2002 ◽  
Vol 88 (3) ◽  
pp. 215-223 ◽  
Author(s):  
Anke Heinig ◽  
Dieter Lampe ◽  
Heinz Kölbl ◽  
Rainer Beck ◽  
Sylvia H Heywang-Köbrunner
Keyword(s):  
Breast Tissue ◽  
Lobular Carcinoma ◽  
Breast Mri ◽  
Tamoxifen Treatment ◽  
Short Term ◽  
Benign Breast Tissue ◽  
Breast Magnetic Resonance ◽  
Antiestrogen Therapy ◽  
Magnetic Resonance Imaging Mri

Aims and Background The value of breast MRI may be impaired by unspecific enhancement. This may leave patients with difficult-to-assess breast tissue with an uncertain diagnosis. We examined whether this unspecific enhancement (which is mostly due to proliferative or hyperplastic changes of benign breast tissue) may be suppressed by antiestrogen medication. Methods In a trial of treatment, 10 peri- or postmenopausal patients who exhibited diffuse and/or focal enhancement on breast MRI before tamoxifen medication agreed to undergo a short-term tamoxifen treatment. MRI monitoring was performed 2, 4 and 8 weeks after onset of antiestrogen therapy (tamoxifen, 30 mg per day). Results Six patients showed a significant decrease of enhancement. Unchanged (n = 3) or increased (n = 1) enhancement was seen in 4 patients. One of the three patients with unchanged enhancement proved to have diffuse lobular carcinoma in situ. Conclusions Part of the unspecific enhancement seen on breast MRI can probably be suppressed by short-term antiestrogen medication.

Benign hepatic cyst in a patient on antiestrogen therapy for metastatic breast cancer

Cancer ◽  
1982 ◽  
Vol 50 (9) ◽  
pp. 1882-1883 ◽  
Author(s):  
Sucha Nand ◽  
Leo I. Gordon ◽  
Elmer Brestan ◽  
Charlotte Harris ◽  
Thomas Brandt
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Hepatic Cyst ◽  
Antiestrogen Therapy
Sign in / Sign up

Export Citation Format

Share Document